Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses

This grant supports research and development of monoclonal antibodies for the prevention and treatment of infections caused by select emerging or re-emerging viruses, strengthening the EU's preparedness and response capacities for infectious disease outbreaks. Expected outcomes include improved scientific access to experimental antibodies, new therapeutic options for epidemic or pandemic settings, and further diversification of prophylactic and therapeutic research capabilities in Europe.

AgencyHORIZON (EU)
RegionEU
CountryN/A
Legal formCompany, NGO, Government organization, Private person, Other
Start date10 Feb 2027
End date13 Apr 2027
Max funding9,000,000–10,000,000 EUR per grant
Budget37,300,000 EUR
Coverage

Not explicitly stated; see Horizon Europe RIA funding rules for typical rates.

Development of monoclonal antibodies to prevent and treat infections from Filo-, Nairo-, Phenui-, Picorna- and Toga viruses • EUGrants.AI